Pharma industry lobbies Trump for phased tariffs, Reuters reports

EU pharma safe from Trump’s tariffs, for now

The president welcomed pharma reshoring plans in remarks Wednesday.

A few hours before the US president's announcements on the imposition of tariffs, rating agencies and markets are attempting to "read" the developments - Trump's team has admitted that the European automotive and pharmaceutical industries are at the center of attention

How worried is Ireland's pharma industry about Trump's tariffs?

Donald Trump’s ‘Liberation Day’ tariffs will be unveiled later today.

Trump's tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks

Leerink Partners analyst David Risinger warned his clients on Sunday that the tariff risks to the industry are 'underappreciated.'

Pharma industry lobbies Trump for phased tariffs, sources say

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and to allow time to shift manufacturing, according to four sources familiar with the discussions.

Trump’s Pharma Threats Take Tariffs Into Uncharted Territory

For more than three decades, the pharmaceutical sector has been protected from tariffs by a World Trade Organization agreement designed to improve access to life-saving drugs.